|Yulong Eco-Materials Ltd （ユロング・エコ・マテリアルズ）
|Capital Goods 資本財（工業製品）
|事業概要 Yulong Eco-Materials Limited is a holding company. The Company is a manufacturer of building products. The Company's segments include Yulong Bricks; Yulong Concrete and Yulong Transport and Yulong Renewable. The Yulong Bricks segment is engaged in the production and sale of fly-ash bricks. The Yulong Concrete and Yulong Transport segment is engaged in the production and sale of ready-mixed concrete. The Yulong Renewable segment is engaged in the hauling and processing of construction waste and production and sale of recycled aggregates and recycled bricks. The Company produces fly ash bricks and ready-mixed concrete. The Company's construction waste management (CWM) business includes hauling and processing construction waste and producing crushed construction waste or recycled aggregates and bricks made from recycled aggregates or recycled bricks. The Company operates principally from the city of Pingdingshan Henan Province in the People's Republic of China. ユロング・エコ・マテリアルズは中国の建設資材メ―カ―。ケイマン諸島籍の持株会社で、子会社を通じ、環境に配慮した建設資材を河南省で製造、販売する。主要製品ははコンクリ―トとブロックで、製造過程を短時間に抑えることにより二酸化炭素の排出を減らす。また、建設中の廃棄物をリサイクルしブロックを製造する。本社は河南省平頂山市。
|Eastern End of Xiwuzhuang Village Jiaodian Town Xinhua Area Pingdingshan Henan Province CHN
|Wancheng Xie Wancheng Xie
|Chairman of the Board 取締役会会長
|NASDAQ Small Cap
|決算概要 BRIEF: For the six months ended 31 December 2017 Yulong Eco-Materials Ltd revenues decreased 9% to $39.6M. Net loss applicable to common stockholders decreased 90% to $5.1M. Revenues reflect Recycling decrease of 25% to $6.6M Concrete decrease of 5% to $21.3M Bricks decrease of 5% to $11.7M. Lower net loss reflects General and administrative decrease of 12% to $11.3M (expense) Interest expense decrease of 21% to $980K (expense).
EV Biologics Signs Exclusive Distribution Agreement for South America 2023/05/15 12:00:00 Accesswire
TAMPA, FL / ACCESSWIRE / May 15, 2023 / EV Biologics Corp (OTC PINK:YECO), today announced that it has signed an exclusive multi-year agreement with INNOVARE for distribution in South America. This agreement will facilitate the launch, in South America and the Caribbean, of EV Biologics regenerative health products, which are currently in production by its wholly owned subsidiary, EXCYTE. INNOVARE has long standing relationships and agreements in place with established medical product companies, which have direct distribution channels throughout South America and the Caribbean. With Joint Ventures already in place, this agreement will provide direct contact with over 11,000 top private-practice physicians and surgeons representing all the medical specialties. INNOVARE will also conduct extensive training modules on these regenerative health products and how they may address patients'' multifaceted and multifactorial health issues and support cardiovascular, dermatologic, neurologic, and musculoskeletal health and longevity.